Interferon-α plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B

AIM: To investigate the efficacy of combination treatment of IFN-α and lamivudine compared to lamivudine monotherapy, after 24 mo of administration in HBeAg-negative hepatitis B patients. METHODS: Fifty consecutive patients were randomly assigned to receive IFN-α-2b (5 MU thrice per week, n = 24) pl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Economou, Michalis, Manolakopoulos, Spilios, Trikalinos, Thomas A, Filis, Spyros, Bethanis, Sotiris, Tzourmakliotis, Dimitrios, Avgerinos, Alec, Raptis, Sotiris, Tsianos, Epameinondas V
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2005
Sujets:
Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4479694/
https://ncbi.nlm.nih.gov/pubmed/16270403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i37.5882
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires